Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis

Background: Although surgery is the mainstay of curative-intent treatment for extrahepatic biliary tract cancer (EBTC), recurrence following surgery can be high and prognosis poor. The impact of neoadjuvant therapy (NAT) relative to upfront surgery (US) among patients with EBTC remains unclear. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoda, Junya, Sahara, Kota, Takahashi, Tomoaki, Miyake, Kentaro, Yabushita, Yasuhiro, Sawada, Yu, Homma, Yuki, Matsuyama, Ryusei, Endo, Itaru, Pawlik, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095506/
https://www.ncbi.nlm.nih.gov/pubmed/37048737
http://dx.doi.org/10.3390/jcm12072654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095506/
https://www.ncbi.nlm.nih.gov/pubmed/37048737
http://dx.doi.org/10.3390/jcm12072654

Ejemplares similares